These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1858578)

  • 1. Human plasma lecithin:cholesterol acyltransferase (LCAT). On the role of essential carboxyl groups in catalysis.
    Jauhiainen M; Dolphin PJ
    Adv Exp Med Biol; 1991; 285():71-5. PubMed ID: 1858578
    [No Abstract]   [Full Text] [Related]  

  • 2. A review on lecithin:cholesterol acyltransferase deficiency.
    Saeedi R; Li M; Frohlich J
    Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lecithin: cholesterol acyltransferase is insufficient to prevent oxidative modification of low-density lipoprotein.
    Murakami Y; Kamiyama S; Howlader ZH; Yamato T; Komai M; Furukawa Y
    J Biochem; 2002 Jan; 131(1):17-9. PubMed ID: 11754730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereochemical substrate requirements of lecithin:cholesterol acyltransferase and its inhibition by enantiomeric lysolecithins.
    Smith NB; Kuksis A
    Can J Biochem; 1980 Nov; 58(11):1286-91. PubMed ID: 7214196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal His6-tagged lecithin-cholesterol acyltransferase (LCAT) is catalytically active.
    Vinogradov DV; Hongqun L; Owen JS
    Biochem Soc Trans; 1998 May; 26(2):S146. PubMed ID: 9649821
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitory effects of lipid oxidation on the activity of plasma lecithin-cholesterol acyltransferase.
    Kamiyama S; Yamato T; Furukawa Y
    Biosci Biotechnol Biochem; 1998 May; 62(5):941-6. PubMed ID: 9648224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lecithin:cholesterol acyltransferase reduces the adverse effects of oxidized low-density lipoprotein while incurring damage itself.
    Howlader ZH; Kamiyama S; Murakami Y; Ito M; Komai M; Furukawa Y
    Biosci Biotechnol Biochem; 2001 Nov; 65(11):2496-503. PubMed ID: 11791724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of N-terminal amino acids from human lecithin:cholesterol acyltransferase differentially affects enzyme activity toward alpha- and beta-substrate lipoproteins.
    Vickaryous NK; Teh EM; Stewart B; Dolphin PJ; Too CK; McLeod RS
    Biochim Biophys Acta; 2003 Mar; 1646(1-2):164-72. PubMed ID: 12637024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lecithin cholesterol acyltransferase (LCAT) and lipoprotein lipase].
    Murase T; Akanuma Y
    Nihon Rinsho; 1983 Aug; 41(8):1747-51. PubMed ID: 6632280
    [No Abstract]   [Full Text] [Related]  

  • 10. Aromatic boronic acids as probes of the catalytic site of human plasma lecithin-cholesterol acyltransferase.
    Jauhiainen M; Ridgway ND; Dolphin PJ
    Biochim Biophys Acta; 1987 Apr; 918(2):175-88. PubMed ID: 3103690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
    Calabresi L; Franceschini G
    Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.
    Freeman LA; Demosky SJ; Konaklieva M; Kuskovsky R; Aponte A; Ossoli AF; Gordon SM; Koby RF; Manthei KA; Shen M; Vaisman BL; Shamburek RD; Jadhav A; Calabresi L; Gucek M; Tesmer JJG; Levine RL; Remaley AT
    J Pharmacol Exp Ther; 2017 Aug; 362(2):306-318. PubMed ID: 28576974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of lecithin:cholesterol acyltransferase (LCAT) activity in hemodialyzed subjects. I. No evidence of plasma LCAT-inhibiting factors.
    Sasso GF; Ceccanti M; Di Giovanni MG; Nardi E; Pilatone P; Pisculli M; Romeo M; Tersigni R; Chiarioni T
    Panminerva Med; 1984; 26(2):97-100. PubMed ID: 6483462
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver tissue lecithin: cholesterol acyltransferase activity in patients with liver disease.
    Ras MR; Frison JC; Rubies-Prat J; Romero R; Masdeu S; Schwartz S
    Biomedicine; 1977 Jun; 27(4):141-3. PubMed ID: 890021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparate effects of oxidation on plasma acyltransferase activities: inhibition of cholesterol esterification but stimulation of transesterification of oxidized phospholipids.
    Subbaiah PV; Liu M
    Biochim Biophys Acta; 1996 May; 1301(1-2):115-26. PubMed ID: 8652646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human lecithin-cholesterol acyltransferase activity by carboxyl-terminal truncation.
    Lee YP; Adimoolam S; Liu M; Subbaiah PV; Glenn K; Jonas A
    Biochim Biophys Acta; 1997 Feb; 1344(3):250-61. PubMed ID: 9059515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylcholine substrate specificity of lecithin: cholestrol acyltransferase-in high density lipoproteins and in lipids dispersions.
    Yokoyama S; Murase T; Akanuma Y
    J Biochem; 1977 Sep; 82(3):719-24. PubMed ID: 199582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HDL2b lipoproteins as an acceptor of cholesterol from erythrocyte membrane and the role of lecithin-cholesterol-acyltransferase during this process].
    Nikiforova AA; Kheĭfets GM; Alksnis EG; Parfenova NS; Klimov AN
    Biokhimiia; 1988 Aug; 53(8):1334-8. PubMed ID: 3191196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of lecithin:cholesterol acyltransferase activity by apolipoprotein A-II in the presence of apolipoprotein A-I.
    Chen CH; Albers JJ
    Eur J Biochem; 1986 Mar; 155(3):589-94. PubMed ID: 3082628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lecithin: cholesterol acyltransferase (LCAT)].
    Hara M; Kinoshita M
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():224-5. PubMed ID: 11351579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.